Brief report
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial)

https://doi.org/10.1016/S0002-9149(02)02844-8Get rights and content

First page preview

First page preview
Click to open first page preview

References (13)

There are more references available in the full text version of this article.

Cited by (108)

  • Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    2017, American Heart Journal
    Citation Excerpt :

    Large observational studies suggest that revascularization is beneficial in patients with renal dysfunction presenting with ACS but is associated with higher rates of procedural complications in this cohort.27-29 In TACTICS-TIMI 18, which compared a routine early invasive versus conservative strategy in patients with non–ST-elevation ACS, the benefits of routine early invasive strategy were preserved in patients with renal dysfunction at the expense of an increased risk of bleeding.30,31 Similarly, in STEMI patients with renal dysfunction, primary PCI is associated with reduced mortality during the index admission but higher rates of bleeding.32

  • Non-ST-Elevation Acute Coronary Syndrome Prognosis

    2017, Encyclopedia of Cardiovascular Research and Medicine
View all citing articles on Scopus
View full text